Kryštof Vladimír

Journals

VARVUOLYTE, G., E. ŘEZNÍČKOVÁ, A. BIELIAUSKAS, N. KLEIZIENE, V. VOJÁČKOVÁ, A. OPICHALOVA, A. ŽUKAUSKAITE, V. KRYŠTOF, A. SACKUS
Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles. Archiv der Pharmazie. 2024, ISSN: 0365-6233, PMID: 38969965,  PDF.
DELGADO, T., V. D., H. DOSTÁLOVÁ, V. KRYŠTOF, V. VOJÁČKOVÁ, R. JORDA, A. CASTRO, J. BERTRAND, G. RIVERA, M. FAUNDEZ, M. STRNAD, C. ESPINOSA-BUSTOS, O. SALAS C.
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024, 16(5), 649, ISSN: 1999-4923, PMID: 38794311,  PDF.
LÖFFELMANN, M., Z. ŠKROTT, D. MAJERA, P. STARHA, V. KRYŠTOF, M. MISTRÍK
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells. European Journal of Medicinal Chemistry. 2023, 261, 115790, ISSN: 0223-5234 , PMID: 37690264,

Doctoral mentorship

Trofimenková Dominika

Cytoprotective effects of novel selenium-based compounds

Status: Ongoing from 2023.